Genius Group Limited and PT Koding Next Indonesia have partnered to launch the Enjoy AI national robotics competition across Indonesia, targeting 1,000 students in its first year. The competition, part of the world's largest youth AI and robotics event, includes training camps and a national final at the Genius Future Festival in Bali in 2027. This initiative supports Indonesia's growing focus on AI and robotics education to meet rising workforce demands in Southeast Asia. Winners will advance to the global Enjoy AI finals, enhancing STEM skills and AI literacy among Indonesian youth.
The launch of the Enjoy AI national robotics competition by Genius Group and Koding Next offers context for technology sector trends. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 05, 2026 19:32 WIB: out of 150 priced US Technology stocks, 50 rose and 95 fell. Notable movers include HubSpot Inc (HUBS) at USD 198.50 with a 1-day change of -8.28%, ASE Technology Holding Co Ltd (ASX) at USD 34.47 down 8.10%, and Arm Holdings plc (ARM) at USD 178.37 down 7.00%. Typical hold times range from 31 to 80 days, with Pluang order activity showing a strong buy interest for ARM at 98%.
On November 4, 2026, Shell plc repurchased a total of 1,876,276 shares across multiple trading venues including LSE, Chi-X, BATS, XAMS, CBOE, and TQEX. The shares were bought at prices ranging from £37.98 to £38.82 and €45.70 to €46.72, with an avera...
Dune has completed a SOC 2 Type II examination with no exceptions, providing institutional clients with verified assurance of its data security standards. This milestone comes as tokenized real-world assets doubled to $32.6 billion and stablecoin mar...
Northern Discovery Metals has finalized the acquisition of a 100% interest in the Cibola copper-gold project in British Columbia from Orogen Royalties. The project covers about 3,567 hectares near Houston, BC, in a region known for porphyry copper de...
Opus Genetics has finished dosing the higher-dose Cohort 2 in its Phase 1/2 trial of OPGx-BEST1, a gene therapy for BEST1-related inherited retinal diseases like Best vitelliform macular dystrophy and autosomal recessive bestrophinopathy. Cohort 2 en...
Perimeter Group Inc. announced a net income of $304.5 million for Q3 2026, reversing a prior year loss of $90.7 million, with net sales up 24% to $389.9 million. Growth was driven by a 14% increase in Fire Safety sales and an 84% surge in Specialty P...
